Release Date: 22/02/17 09:17 Summary: Investor Presentation - RIU Explorers Conference Price Sensitive: No Download Document 2.19MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%